📰 Compass Pathways News
Page 10 - Compass Pathways News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Compass Pathways. Real-time updates on events, politics, business and more.
December 19, 2023
Shares of COMPASS Pathways plc (NASDAQ:CMPS – Get Free Report) have earned a consensus recommendation of “Buy” from the six research firms that are covering the firm, Marketbeat Ratings reports. Six analysts have rated the stock with a buy rating. The average 1-year price objective among brokers that have issued ratings on the stock in […]
December 19, 2023
By Sabela Ojea Compass Pathways said early data from its post-traumatic stress disorder phase 2 clinical trial showed the psilocybin treatment was well...
December 19, 2023
Initial safety findings at 24 hours post dosing were consistent with studies of COMP360 in other psychiatric conditionsLONDON, Dec. 19, 2023 -- Compass Pathways plc , a biotechnology company...
December 15, 2023
Deutsche Bank Aktiengesellschaft started coverage on shares of COMPASS Pathways (NASDAQ:CMPS – Free Report) in a research note published on Tuesday, Marketbeat.com reports. The brokerage issued a buy rating and a $16.00 target price on the stock. Several other brokerages also recently issued reports on CMPS. Cantor Fitzgerald reaffirmed an overweight rating and issued a […]
December 13, 2023
In this article, we will be looking at the 25 best online psychology degree programs heading into 2024.
December 8, 2023
This Viewpoint examines how US states are reforming legislation to allow access to psychedelics for therapeutic use, but federal laws consider these agents to b
December 6, 2023
/PRNewswire/ -- JAMA Psychiatry recently published a first-of-its-kind clinical trial conducted at Sheppard Pratt studying the efficacy and safety of a single...
December 6, 2023
Believed to be first ever psilocybin clinical trial for treatment of bipolar II depressionLONDON, Dec. 06, 2023 -- Compass Pathways plc , a biotechnology company dedicated to accelerating patient...
November 28, 2023
Investor Ideas Potcasts: Interview with Kaya Holdings (OTCQB: KAYS) on the Sacred Mushroom Center - Pioneers with Psilocybin and Advocates for Mental Health
November 28, 2023
Investorideas.com, a global news source covering leading sectors including marijuana and psychedelic stocks releases a special edition of the top rated Investor Ideas potcast .In todays episode,...